Livforsakringsbolaget Skandia, Omsesidigt Bio Techne Corp Transaction History
Livforsakringsbolaget Skandia, Omsesidigt
- $1.85 Billion
- Q4 2024
A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Bio Techne Corp stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 878 shares of TECH stock, worth $57,895. This represents 0.0% of its overall portfolio holdings.
Number of Shares
878
Previous 1,378
36.28%
Holding current value
$57,895
Previous $110,000
42.73%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding TECH
# of Institutions
616Shares Held
156MCall Options Held
200KPut Options Held
15.3K-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.23 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$988 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.7MShares$703 Million0.09% of portfolio
-
State Street Corp Boston, MA6.47MShares$427 Million0.02% of portfolio
-
Morgan Stanley New York, NY4.76MShares$314 Million0.02% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.59B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...